Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Adrenal Cortex Cancer

rosiglitazone has been researched along with Adrenal Cortex Cancer in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cantini, G; Ercolino, T; Francalanci, M; Gelmini, S; Lombardi, A; Luconi, M; Mangoni, M; Mannelli, M; Nesi, G; Orlando, C; Pepi, M; Poli, G; Pratesi, N; Serio, M1
Amendola, D; Bucci, B; Cerquetti, L; De Venanzi, A; Marchese, R; Masuelli, L; Misiti, S; Poggi, M; Sampaoli, C; Stigliano, A; Toscano, V1
Ceni, E; Ferruzzi, P; Fiorelli, G; Galli, A; Grappone, C; Mannelli, M; Milani, S; Serio, M; Tarocchi, M1
Betz, MJ; Beuschlein, F; Fassnacht, M; Hahner, S; Reincke, M; Shapiro, I1

Other Studies

4 other study(ies) available for rosiglitazone and Adrenal Cortex Cancer

ArticleYear
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model.
    Endocrine-related cancer, 2010, Volume: 17, Issue:1

    Topics: Adrenal Cortex Neoplasms; Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoglycemic Agents; Mice; Mice, Nude; Rosiglitazone; Thiazolidinediones; Tumor Burden; Xenograft Model Antitumor Assays

2010
Rosiglitazone induces autophagy in H295R and cell cycle deregulation in SW13 adrenocortical cancer cells.
    Experimental cell research, 2011, Jun-10, Volume: 317, Issue:10

    Topics: Adrenal Cortex Neoplasms; Apoptosis; Autophagy; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin E; Fluorescent Antibody Technique; Humans; Hypoglycemic Agents; Membrane Potential, Mitochondrial; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones

2011
Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:3

    Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Cell Division; Cell Line, Tumor; Female; Humans; Hypoglycemic Agents; Matrix Metalloproteinase 2; Middle Aged; Neoplasm Invasiveness; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tumor Cells, Cultured

2005
Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:7

    Topics: Adrenal Cortex Neoplasms; Adult; Aged; Anilides; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin E; Dose-Response Relationship, Drug; Female; Humans; Insulin-Like Growth Factor II; Male; Middle Aged; PPAR gamma; Promoter Regions, Genetic; Receptor, Melanocortin, Type 2; RNA, Messenger; Rosiglitazone; Thiazolidinediones

2005